<< Вернуться к списку статей журнала

Том 8 №1 2006 год - Нефрология и диализ

Контраст-индуцированная нефропатия: патогенез, факторы риска, стратегия профилактики (Часть I)

Волгина Г.В.

Аннотация: В течение последних 30 лет значительно увеличилось применение рентгеноконтрастных средств (РКС) при проведении урографии, ангиографии, компьютерной томографии и операционных процедур. Ежегодно в мире используется около 60 миллионов доз РКС, но, несмотря на использование более новых и менее нефротоксичных препаратов, риск контраст-индуцированной нефропатии (КИН) остается значительным, особенно среди пациентов с предшествующим нарушением функции почек. Контраст-нефропатия является серьезной причиной острого поражения почек и представляет собой актуальную проблему в клинической практике. До настоящего времени остаются противоречия в понимании многих аспектов КИН. В настоящем обзоре обсуждаются взгляды на проблему патогенеза, факторы риска и достижения в профилактике КИН.

Для цитирования: Волгина Г.В. Контраст-индуцированная нефропатия: патогенез, факторы риска, стратегия профилактики (Часть I). Нефрология и диализ. 2006. 8(1):69-77. doi:

Весь текст

Ключевые слова: рентгеноконтрастные средства, нефропатия, факторы риска, патогенез, профилактика

Список литературы:

1. Agmon Y., Peleg H., Greenfeld Z. et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94: 1069-1075.
2. Alexanian R., Barlogie B., Dixon D. Renal failure in multiple myeloma: pathogenesis and prognostic implications. Arch Intern Med 1990; 140: 1693-1695.
3. Almén T., Frennby B., Sterner G. Determination of glomerular filtration rate (GFR) with contrast media. In: Thomsen H.S., Muller R.N., Mattrey R.F., editors. Trends in contrast media. Berlin: Springer Verlag 1999: 81-94.
4. Anderson R.J., Linas S.L., Berns A.S. et al. Nonoliguric acute renal failure. N Engl J Med 1977; 296:1134-1138.
5. Aspelin P., Aubry P., Fransson S.-G. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. N Engl J Med 2003; 348(6): 491-499.
6. Baker L.R.I. Drugs and the kidney. In: Kumar P., Clark M., eds.Clinical medicine, 4th ed. London, England: Saunders 1998: 565-567.
7. Bakris G.L., Burnett J.C.J. A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int 1985; 27: 465-468.
8. Bakris G.L., Lass N.A., Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int 1999; 56: 206-210.
9. Baliga R., Ueda N., Walker P.D., Shah S.V. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997; 29: 465-477.
10. Barrett B.J., Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188:171-178.
11. Barrett B.J., Parfrey P.S. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994; 331: 1449-1450.
12. Barrett B.J. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-137.
13. Battenfeld R., Khater A.R., Drommer W., Guenzel P., Kaup F.-J. Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol 1991; 26:35-39.
14. Berg K.J. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000; 34: 317-322.
15. Berns J., Rudnick M. Radiocontrast media associated nephrotoxicity. Kidney 1992; 24: 1-5.
16. Bostom A.G., Kronenberg F., Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13: 2140-2144.
17. Brady R.B., Singer G.G. Acute renal failure. Lancet 1995; 346: 1533-1540.
18. Brezis M., Rosen A.S. Hypoxia of the renal medulla: its implications for disease. N Engl J Med 1995; 332: 647-655.
19. Byrd L., Sherman R.L. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine1979; 58: 270-279.
20. Chalmers N., Jackson R.W. Comparasion of iodixanol and iohexol in renal impairment. Brit J Radiol 1999; 72: 701-703.
21. Conlon P.J., Little M.A., Pieper K., Mark D.B. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001; 60: 1490-1497.
22. Davidson C.J., Hlatky M., Morris K.G. et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med 1989; 110: 119-124.
23. Dawnay A.B.S.J., Thornley C., Nockler I., Webb J.A.W., Cattel W.R. Tamm-Horsfall glycoprotein excretion and aggregation during intravenous urography: relevance to acute renal failure. Invest Radiol 1985; 20: 53-57.
24. Deray G., Dubois M., Martinez F. et al. Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 1990; 10: 507-513.
25. Deray G., Martinez F., Cacoub P. et al. A role for adenosine, calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990; 10: 316-322.
26. Freeman R.V., O'Donnell M., Share D. et al. Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073.
27. Gleeson T., Bulugahapitiya S. Contrast-Induced Nephropathy. Am J Roentgenol 2004; 183(6): 1673-1689.
28. Goldenberg I., Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 24:172 (11).
29. Gouyon J.B., Guignard J.P. Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int 1988; 33: 1078-1083.
30. Gruberg L., Waksman R., Ajani A.E. et al. The effect of intracoronary radiation for the treatment of recurrent instent restenosis in patients with chronic renal failure. J Am Coll Cardiol 2001; 38: 1049-1053.
31. Grynne B.H., Nossen J.D., Bolstad B., Borch K.W. Main results of the first comparative clinical studes on Visipaque. Acta Radiol 1995; 36: 265-270.
32. Haylor J.L., El Sayed A.A., El Nahas A.M., Morcos S.K. The effect of sodium iothalamate on the vascular resistance of the isolated perfused rat kidney. Br J Radiol 1991; 64: 50-54.
33. Hemmelgarn B.R., Ghali W.A., Quan H. et al. Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis 2001; 37: 64-72.
34. Heyman S.N., Brezis M., Epstein F.H. et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632-642.
35. Heyman S.N., Clark B.A., Kaiser N. et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992; 3: 58-65.
36. Heyman S.N., Rosen S., Brezis M. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994; 2: 153-157.
37. Hizoh I., Strater J., Schick C.S., Kubler W., Haller C. Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant 1998; 13: 911-918.
38. Jakobsen J.A., Bjorg L., Kristoffersen D.T. et al. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. Radiology 1992; 182: 419-424.
39. Kappel J., Calissi P. Nephrology: 3. Safe drug prescribing for patients with renal insufficiency. Can Med Assoc J 2002; 166: 473-477.
40. Katholi R.E., Taylor G.J., McCann W.P. et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995; 195: 17-22.
41. Katzberg RW. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204: 297-312.
42. Kolonko A., Wiecek A. Contrast-associated nephropathy: old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant 1998; 13: 803-806.
43. Lancelot E., Idee J.-P., Lacledere C., Santus R., Corot C. Effects of two dimeric iodinated contrast media on renal medullary blood perfusion and oxygenation in dogs. Invest Radiol 2002; 37: 368-375.
44. Levy E.M., Viscoli C.M., Horwitz R.I. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275: 1489-1494.
45. Liss P., Nygren A., Erikson U., Ulfendahl H.R. Injection of low and iso-osmolar contrast media decreases oxygen tension in the renal medulla. Kidney Int 1998; 53: 698-702.
46. Liss P., Nygren A., Olsson U., Ulfendahl H.R., Erikson U. Effects of contrast media and mannitol on renal renal medullary blood flow and aggregation in the rat kidney. Kidney Int 1996; 49: 1268-1275.
47. Manske C.L., Sprafka J.M., Strony J.T. et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89(5): 615-620.
48. Marenzi G., Marana I., Lauri G. et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-1340.
49. McCarthy C., Becker J. Multiple myeloma and contrast media. Radiology 1992; 183: 519-521.
50. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., O'Neill W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.
51. Moore R.D., Steinberg E.P., Power N.R. et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992; 182: 649-655.
52. Morcos S.K., Thomsen H.S., Webb J.A.W. and members of contrast media safety committee of the European Society of Urogenital Radiology (ESUR). Contrast media induced nephrotoxicity: A consensus report. Eur Radiol 1999; 9: 1602-1613.
53. Morcos S.K. Contrast media-induced nephrotoxicity: questions and answers. Br J Radiol 1998; 71: 357-365.
54. Morcos S.K. Prevention of contrast media nephrotoxicity - the story so far. Clin Radiol 2004; 59: 381-389.
55. Murphy M.E., Tublin M.E., Li S. Influence of contrast media on the response of rat renal arteries to endothelin and nitric oxide: influence of contrast media. Invest Radiol 1998; 33: 356-365.
56. Nash K. Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
57. Oldroyd S.D., Haylor J.L., Morcos S.K. Bosentan: an orally active endothelin antagonist - effect on renal response to contrast media. Radiology 1995; 19: 661-665.
58. Parfrey P.S., Griffiths S.M., Barrett B.J., Paul M.D., Genge M., Withers J. et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149.
59. Prasad P.V., Priatna A., Spokes K., Epstein F.H. Changes in intra-renal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 2000; 13: 744-747.
60. Reed J.R., Williams R.H., Luke R.G. The renal hemodynamic response to diatrizoate in normal and diabetic rats. Invest Radiol 1983; 18: 536-540.
61. Reis S.E., Olson M.B., Fried L. et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002; 105: 2826-2829.
62. Rezkalla S.H. Contrast Nephropathy. Clinical Medicine 2003; 1(4): 301-304.
63. Rihal C.S., Textor S.C., Grill D.E. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264.
64. Rudnick M., Berns J., Cohen R., Goldfarb S. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis 1994; 24: 713-727.
65. Rudnick M.R., Goldfarb S., Wexler L. et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47(1): 254-261.
66. Russo D., Minutolo R., Cianciaruso B., Memoli B., Conte G., De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451-1458.
67. Safirstein R., Andrade L., Vieira J.M. Acetylcysteine and nephrotoxic effects of radiographic contrast agents: a new use for an old drug. N Engl J Med 2000; 343: 210-212.
68. Simon E.E. Potential role of integrins in acute renal failure. Nephrol Dial Transplant 1994; 9 [suppl 4]: 26-33.
69. Solomon R., Werner C., Mann D., D'Elia J., Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420.
70. Solomon R. Contrast medium-induced acute renal failure. Kidney Int 1998; 53: 230-242.
71. Stevens M.A., McCullough P.A., Tobin K.J. et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. study - Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-411.
72. Taliercio C.P., Vlietstra R.E., Ilstrup D.M. et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high-risk patients undergoing cardiac angiography. J Am Coll Cardiol 1991; 17: 384-390.
73. Thomsen H.S., Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) Guidelines. British Journal of Radiology 2003; 76: 513-518.
74. Thomsen H.S., Golman K., Hemmingsen L. et al. Contrast medium induced nephropathy: Animal experiments. Frontiers Eur Radiol 1993; 9: 83-108.
75. Thomsen H.S., Morcos S.K. Radiographic contrast media. BJU Int 2000; 86 [suppl 1]: 1-10.
76. Tublin M.E., Murphy M.E., Tessler F.N. Current concepts in contrast media-induced nephropathy. AJR 1998; 171: 933-939.
77. Ueda J., Nygren A., Hansell P., Ulfendahl H.R. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiologica 1993; 34: 83-87.
78. Vaitkus P.T. Current status of prevention, diagnosis, and management of coronary artery disease in patients with kidney failure. Am Heart J 2000; 139: 1000-1008.
79. Wang A., Holcslaw T., Bashore T.M. et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000; 57: 1675-1680.
80. Waybill M.W., Waybill P.N. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001; 12: 3-9.
81. Weinbroum A.A., Reduck V., Ben-Abraham R., Karchevski E. N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272: F292-F298.
82. Weisberg L.S., Kurnik P.B., Kurnik B.R. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992; 41: 1408-1415.
83. Weisberg L.S., Kurnik P.B., Kurnik B.R. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259-265.
84. Yoshioka T., Fogo A., Beckman J.K. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992; 41: 1008-1015.

Другие статьи по теме

• К патогенезу диализного перитонита
• Роль вирусной инфекции в патогенезе гломерулонефрита у детей. Современные подходы к иммунокорригирующей терапии (Лекция)
• Вирусные гепатиты. Особенности в условиях заместительной терапии хронической почечной недостаточности Лекция, часть 2
• Антиретровирусная терапия и почки: Баланс пользы и риска у пациентов с ВИЧ-инфекцией. Обзор литературы